Asterin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.80 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 34.35%
- Profit Growth -25.82%
- Ebitda 25.12%
- Net Worth 31.02%
- Total Assets 15.69%
About Asterin Pharmaceuticals
Asterin Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 July 2020 (Four years and six months 15 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Tanvirsinh Bhavanisinh, Amrish Solanki, Himanshu Acharya, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299GJ2020PTC114791
-
Company No.
114791
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jul 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Asterin Pharmaceuticals Private Limited offer?
Asterin Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Asterin Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanvirsinh Bhavanisinh
|
Director | 19-Jul-2020 | Current |
|
Amrish Solanki
|
Director | 19-Jul-2020 | Current |
|
Himanshu Acharya
|
Director | 19-Jul-2020 | Current |
|
Jayantilal Patel
|
Director | 19-Jul-2020 | Current |
Financial Performance of Asterin Pharmaceuticals.
Asterin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.35% increase. The company also saw a substantial fall in profitability, with a 25.82% decrease in profit. The company's net worth Soared by an impressive increase of 31.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asterin Pharmaceuticals?
Unlock access to Asterin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asterin Pharmaceuticals?
Asterin Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asterin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asterin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.